MIAMI--(BUSINESS WIRE)--Jan. 3, 2006--SFBC International, Inc. (NASDAQ: SFCC), a provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, said today that its board of directors has appointed Jeffrey P. McMullen as chief executive officer replacing Arnold Hantman, who is retiring. The Board also has accepted the resignation of Dr. Lisa Krinsky, who served as the company’s president and chairman.
